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ABSTRACT   
Introduction: Although control strategies for antimicrobial resistance (AMR) have been described 
in high-income settings, interventions to curb the emergence and spread of AMR in conflict-
afflicted low- and middle-income countries (LMICs) have not been systematically explored.   
Objective: The objective of this review was to identify and assess the effectiveness of various 
control strategies in curbing the emergence and spread of AMR in conflict-afflicted LMICs. 
Methods: A systematic scoping review of the literature was conducted using Embase, PubMed, and 
Scopus to identify primary literature reporting on AMR in Pakistan, Lebanon, Jordan, or Turkey 
published in the last decade (Jan. 2010 – Jan. 2020). Papers were eligible for inclusion if they 
discussed conflict or the effects thereof, AMR, and control strategies for AMR. Summary and 
reporting of the findings were informed by guidelines presented by Tricco et al. 2018 and the JBI 
Reviewer’s Manual for scoping reviews. Semi-structured interviews with experts were conducted to 
substantiate review findings. All interviews were audio-recorded and transcribed in full using the 
website OTranscribe and the software Descript V.3.3.2. 
Results: Sixteen articles were deemed eligible for inclusion. Control strategies discussed in these 
articles fell into five categories: infection prevention and control (n=4); antibiotic stewardship 
programs (n=3); diagnostics and surveillance (n=7); education (n=2); and other (n=2). 
Conclusion: The challenges associated with controlling the emergence and spread of AMR are 
exacerbated by violent conflict and displacement. Conflict-afflicted LMICs not only face resource 
limitations, but must also find ways to care for and treat injured individuals carrying increasingly-
resistant pathogens. The literature and expert opinions suggest that improved lab diagnostics, 
implementation of surveillance programs, and infection prevention and control should be prioritized 
as AMR control strategies in conflict-afflicted LMICs. However, there is limited research on the 
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effectiveness of these interventions in such settings. Future research is needed before adequate 
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Background & Rationale  
 
Rates of antimicrobial resistance (AMR) are on the rise globally.1 Resistance itself emerges when a 
subset of pathogens survives within an individual following treatment with an antimicrobial. These 
surviving pathogens are oftentimes fitter strains of the microbe which have developed mechanisms 
to evade both drug treatment and the immune system. The use of antimicrobials, such as antibiotics, 
kill off commensal and pathogenic bacteria in a host. In the absence of competition, resistant-
microbes multiply. Resistance is subsequently spread to other individuals and, in some cases, 
resistance may be passed directly from one microbe to another.2 While complications associated 
with the treatment of resistant infection and disease endanger the wellbeing of individuals around 
the world – claiming nearly 700,000 lives yearly – the burden of AMR is disproportionality felt by 
low- and middle-income countries (LMICs).i,4 This imbalance is due to challenges such as weak 
governance, economic factors, and technological limitations which oftentimes make it difficult for 
LMICs to appropriately manage the emergence and spread of AMR within their borders.4  
As the body of literature on AMR in LMICs continues to grow, the difficulties that these 
countries face in curbing the emergence and spread of AMR become increasingly apparent. 
Solutions such as increased screening for infectious disease,5,6 infection prevention and control,5–7 
and improved policy implementation8 have all been suggested. However, the implementation of 
such interventions is difficult given resources limitations in many LMICs. The barriers to AMR 
control are even greater in LMICs affected by conflict,ii as can be seen in several countries in the 
Middle East and North Africa (MENA) region. In Syria, for example, existing drivers of AMR – 
 
i A country is designated an LMIC based on gross national income per capita cut-offs defined by the World Health 
Organization.3 
ii “Conflict,” as it will be used throughout this paper, is defined by Bowsher et al. 2019 and Pettersson et al. 2015 as 
“violent armed struggle between hostile groups, resulting in over 25-battle related deaths per year.”3,9 
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including the misuse of antibiotics and a lack of early diagnosis of communicable diseases – were 
exacerbated by the onset of the civil war in 2011, in part due to the breakdown of the healthcare 
system.5,10 Studies on Iraq, a country plagued with political instability and violence since the United 
States invaded in 2003, speculate that lack of adequate infection prevention programs in healthcare 
clinics, along with poor management of antibiotics, have led to the emergence and nosocomial 
transmission of multi-drug resistance (MDR).11,12 Other drivers of AMR worsened by conflict 
include delayed access to care, crowded and unsanitary healthcare facilities, shortages in vaccine 
supply, and disruption of vaccination schedules.10,13  
What’s more, refugees and civilians displaced from conflict-afflictediii regions may 
themselves serve as carriers of MDR pathogens, exposing populations in neighboring countries to 
increasingly difficult-to-treat diseases.10,14,15 Factors such as poor hygiene, lack of adequate housing, 
and inaccess to healthcare services along migration routes all perpetuate this spread of 
AMR.6,16,17AMR therefore poses threat not only to citizens of countries affected by active conflict, 
but also to surrounding LMICs that serve as host and caretaker of the massive number of displaced 
individuals.   
According to a 2018 report released by the United Nations Refugee Agency (UNHCR), the 
LMICs with the highest number of refugees and displaced peoples relative to their national 
population include Lebanon (1 in 6 individuals currently living in Lebanon is a refugee), Jordan (1 in 
14), and Turkey (1 in 22).18 This same report lists Pakistan as the country hosting the second largest 
total number of refugees, with Turkey hosting the most out of any country in the world.18 The 
political, social, and ecological realties in each of these four countries vary vastly. However, they are 
alike in that recent studies indicate that the emergence and spread of AMR in these countries is 
 
iii “Conflict-afflicted,” as it will be used throughout this paper, may refer to a region actively experiencing violent armed 
struggle or otherwise experiencing the social and political after-effects of conflict.3 These social and political effects may 
include internal displacement or a high volume of refugees entering the country.3    
 8 
partially attributable to the flow of migrants, refugees, and injured civilians through their borders. In 
Turkey, which contained nearly 2.7 million Syrian refugees in 2016, increased rates of MDR bacterial 
infections in war-wounded patients – along with the re-emergence of measles, poliomyelitis, 
leishmaniasis, and MDR-tuberculosis (TB) – have provoked concerns over biosecurity within the 
country.10 In Jordan, a systematic review found that measles, MDR-TB, and cutaneous leishmaniasis 
are also re-emerging there due to the rapid influx of Syrian refugees.19 In Lebanon, a review of data 
from 13 hospitals across the country found that there was an observed decrease of 5-10% in the 
susceptibility of bacteria to major classes of antibiotics in 2015-2016 compared to 2011-2013.20 In 
Pakistan, there is a growing epidemic of cutaneous leishmaniasis in towns neighboring Afghanistan 
and in cities with a high number of refugees; increased variability in the clinical presentation of this 
disease had complicated treatment and diagnosis.21  
The emergence and re-emergence of resistant infectious diseases in these countries 
demonstrates the need for increased research on how to control AMR in conflict-afflicted settings. 
To the author’s knowledge, this paper will be the first time that the literature has been systematically 
searched in order to compile research on control strategies and recommendations put forth by 
individuals working in places most affected by the conflict and displacement in the MENA region. 
The objective of this review is to compile evidence-based control strategies for AMR in conflict-
afflicted LMICs and to identify existing research gaps. The goals of this thesis are threefold: (1) 
present what is currently being done to address AMR in conflict-afflicted LMICs; (2) compile 
recommendations for control put forth by scholars, scientists, and others in the MENA region; (3) 
conduct interviews with experts in order to substantiate findings and expand recommendations for 
AMR control in resource-variable settings. The qualitative component of this thesis was deemed 
exempt by the Institutional Review Board at Yale University.  
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It is the author’s hope that this project will help stakeholders to identify gaps in the literature 
and inform future research projects on the complex interactions between conflict, displacement, and 
AMR. Persistent instability in the MENA region threatens the health and well-being of millions of 
people. It is urgent that the global health community more seriously consider conflict as a public 
health threat and work toward effective and feasible interventions in the regions most affected.    
METHODS  
Search Strategy  
A systematic scoping review of the literature was conducted using the Joanna Briggs Institute (JBI) 
Reviewer’s Manual guidelines on scoping review methodology and summary of evidence.22 The 
search was conducted using Embase, PubMed, and Scopus to identify peer-reviewed primary 
literature reporting on AMR in Pakistan, Lebanon, Jordan, or Turkey published in the last decade 
(Jan. 2010 – Jan. 2020). The structure of the search and summary of the findings was informed by 
guidelines presented by Tricco et al. 2018 and the JBI Reviewer’s Manual for scoping reviews.22,23 
The author used a Boolean search strategy to combine search terms related to three topic 
areas: (1) antimicrobial resistance AND (2) conflict or displacement AND (3) study based in one of 
the four specified countries of interest. An initial search was conducted in PubMed. The author 
reviewed topical articles, reports, and editorial pieces in order to generate a comprehensive list of 
relevant keywords. All identified keywords were carefully tracked in a Microsoft Excel V. 16.31 
spreadsheet. A Medical Subject Headings (MeSH) search was conducted using an initial list of 
keywords and a review of MeSH tree structures helped to identify additional terms related to the 
topics of interest. A complete search of all relevant keywords and MeSH terms was then conducted 
in PubMed and 220 records were returned (Table 1).  
The platform OVID was used to search articles in Embase. The list of terms identified in the 
PubMed search was expanded to include search terms specific to Embase. The author used the 
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“Tree Search Tool,” which compiles a list of related searches based on one keyword, to identify 
Embase-specific terminology relevant to each of the three topic areas of interest. A comprehensive 
search of all identified terms was conducted and 158 records were identified (Table 1). Finally, a 
search was conducted in Scopus using the previously identified terms related to the three topic areas 
of interest. This search returned 221 records (Table 1).  
Table 1 in the Appendix includes a full list of the search terms used for each database. In 
total, searches across the three databases returned 599 records. 
As per JBI guidance, the author also conducted a number of interviews in order to 
substantiate the findings of this scoping review.22 The goal of these interviews was to gain expert 
opinion on evidence-based control strategies for AMR in LMICs. Furthermore, these interviews 
provided the opportunity to much more explicitly explore the role of violent conflict in the 
emergence and spread of AMR, as each interlocutor had some amount of expertise working in 
regions or with patients affected by warfare. All interviews were audio-recorded and transcribed in 
full by the author using the website OTranscribe and the software Descript V.3.3.2. Major themes 
that emerged from these interviews are explored in the Discussion section of this paper.  
Inclusion Criteria  
All records identified in the search stage were imported to EndNote X9, a citation management 
software. One hundred fifty-two duplicate records were eliminated and 447 records were identified 
for title and abstract screening. Three hundred ninety-nine articles were subsequently excluded for 
the following reasons: published before January 2010 (n=156); not topically relevant (i.e., no explicit 
discussion of the three topic areas of interest) (n=237); full-text article was not in English (n=6). 
Forty-eight records were thus identified for full-text screening.   
To be eligible for inclusion in the review, studies had to be primary research on a topic 
related to both antimicrobial resistance and conflict, and be based in Turkey, Pakistan, Jordan, or 
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Lebanon. Study types could include retrospective or prospective cohort studies, randomized control 
trials, database analyses, or qualitative research studies. Systematic reviews, opinion pieces, editorials, 
letters, conference abstracts, and pilot studies were excluded (n=23). To be eligible for inclusion, 
articles also had to discuss interventions or strategy recommendations for AMR control. Articles did 
not have to discuss the effectiveness of recommended control strategies to be included in this 
review. While some studies did provide supporting evidence for the effectiveness of their suggested 
control strategies, most mentioned control in their discussion section. Nine articles were excluded 
because they did not discuss control.  
RESULTS  
After screening, 16 articles met the eligibility criteria and 
were included in this scoping review (Fig. 1). Six studies 
were based in Jordan,12,24–28 two in Pakistan,29,30 six in 
Lebanon,31–36 and two in Turkey.37,38 Study populations 
included Iraqi, Yemeni, and Syrian 
civilians/pateints,12,24,26,37,38 Palestinian refugees,27 Syrian 
refugees,31–33,36 Afghani refugees,29 Lebanese patients 
and/or individuals residing in Lebanon,32–35physicians in 
Jordan,25,28 Turkish patients,38 and others30 (Table 2). 
These descriptions of study populations mimic the language used by study authors to describe them, 
as not all study authors provided sufficient information on the migration status of their study 
population. Ten studies were conducted in a hospital or healthcare clinic,12,24–28,31,32,37,38 two studies 
were community based,29,30 and four studies were laboratory based.33–36 Further details on each study 
can be found in Table 2 in the Appendix.  
Figure 1 
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All 16 studies included in this scoping review contained interventions or strategy 
recommendations for the control of AMR in conflict-afflicted LMICs. Control strategies fell into 
five categories: infection prevention and control (IPC);26,31,32,37 antibiotic stewardship programs 
(ASP);12,24,26 diagnostics and surveillance (DS);12,30,33–36,38 education (E);25,27 and other (O).28,29  
A complete list of strategy recommendations can be found in Table 3 in the Appendix. Each 
strategy type will be explored in further detail below.  
Infection Prevention and Control (IPC) 
There is some literature to support the effectiveness of infection prevention and control (IPC) to 
reduce the emergence and transmission of MDR pathogens in high-income settings.39,40 IPC 
interventions include: patient screening, patient isolation, disease surveillance, improved 
environmental hygiene, education and training of healthcare personnel, and “judicious use of 
antimicrobial agents.”39,40 The goals of IPC are to either prevent infection altogether – thus 
preventing the emergence of resistant pathogens – or to control infections such that patients 
carrying resistant pathogens are unable to spread them, particularly nosocomially. Four studies 
included in this review suggest IPC as a control strategy for AMR in LMICs.  
In Lebanon, Rafei and Dabbousi et al., 2013 tested patient samples obtained from war-
wounded Syrian refugees treated for carbapenem-resistant Acinetobacter baumannii in 2012 at the 
Tripoli Government Hospital.31 A. baumannii is an opportunistic nosocomial pathogen that is 
associated with high morbidity and mortality and also has an ability to rapidly acquire resistance.32,41 
It is a common cause of infection in war and combat wounds.41 The researchers tested four isolates 
from patients and found that each contained the resistance-causing gene blaNDM – “the first detection 
of carbapenem-resistant A. baumannii carrying the blaNDM gene in Lebanon.”31 They were unable to 
identify the source of A. baumannii infection, but concluded that Syria likely serves as a reservoir for 
NDM-producing bacteria.31 Based on these study findings, the authors recommend that Lebanese 
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hospitals treating Syrian refugees implement infection control measures to prevent the spread of 
MDR A. baumannii  in healthcare institutions.31 
A subsequent study by Rafei (Rafei and Pailhories et al. 2015) tested 116 samples obtained 
from Syrian and Lebanese patients (78% male, mean age 40) treated at different hospitals in Tripoli, 
Lebanon between 2011 and 2013 for antibiotic susceptibility.32 They found that 60% of the isolates 
showed phenotypes consistent with carbapenem resistance: five isolates (four from Syrian patients 
and one from a Lebanese patient) exhibited the blaNDM gene.32 The authors speculate that Syrian 
refugees likely acquired the infection during a hospital stay in Syria and carried the resistant-
pathogen to Lebanon, but data to support this speculation was limited.32 In Europe, A. baumannii 
susceptibility to antibiotics has decreased from 52.9% in 2009 to 37.7% in 2011; the study authors 
share concerns that the emergence of NDM in Lebanon may result in comparable reductions in 
antibiotic susceptibility of this nosocomial pathogen.32 Based both on their findings and the fact that 
Tripoli is proximate to the Syrian border, the study authors conclude that effective measures to 
control the spread of infection in Lebanon are necessary.32 However, the authors do not offer 
examples of any specific measures.  
In Turkey, Yuce et al. 2017 retrospectively analyzed data collected from Syrian patients 
treated for conflict-associated burns at the Dr. Lutfi Kirdar Kartal Educating and Training Hospital 
Burn Centre of Istanbul between 2011 and 2015.37 The purpose of this study was to describe the 
type of burn wounds that Syrian patients presented with and to provide details on wound-
management at the burn center.37 According to the authors, analysis of tissue cultures from these 
burn victims revealed resistant microorganisms “specific to the battlefield.”37 The authors also 
reported nosocomial spread of these resistant-microorganisms in their treatment center, despite 
attempts to isolate Syrian patients presenting with war wounds.37 The authors conclude that rapid 
transfer of patients with war-associated burns to treatment centers equipped to treat such wounds is 
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crucial for infection prevention.37 Early debridement and sterilization of such wounds further helps 
to improve treatment outcomes.37  
Alga and Herzog et al. 2018a conducted a qualitative study with physicians employed in a 
hospital supported by Médecins Sans Frontières (MSF) in Jordan. The goal of their study was to 
understand how physicians working in an LMIC and treating war-wounded patients think about 
AMR and healthcare-associated infections (HAI).25 The authors interviewed 10 physicians (55% 
male, mean age 37).25 All interviews were transcribed and content analyzed by the study authors.25 
When asked about HAI, physicians recognized a lack of staff adherence to hospital protocols as 
attributable to the spread of pathogens.25 However, physicians qualified this lack of adherence with a 
limitation of resources as a reason that adherence proved difficult.25 Specifically, physicians cited lack 
of bed sheets, shortage of appropriate antibiotics, and space limitations as barriers to infection 
prevention.25 On the topic of AMR, participants cited main challenges as being costs associated with 
antibiotic treatment and space limitations that precluded antibiotic-resistant patients from being 
isolated.25 Physicians also pointed out that antibiotics are commonly available over the counter in 
Syria and Lebanon, and therefore patient behavior might also be a contributing factor to AMR 
emergence.25 The findings from this study present just some of the challenges to IPC in a resource-
limited setting. The authors believe that increased access to resources (e.g., bed sheets, antibiotics, 
etc.) is necessary for control AMR in this setting.25 
Antibiotic Stewardship Program (ASP) 
Inappropriate antibiotic use and prescribing are not only burdensome and costly to healthcare 
systems, but also drive the emergence of multi-drug resistant pathogens and organisms.24,42,43 An 
ASP is a program in which antibiotic use within a healthcare institution is monitored or directed by a 
trained group of individuals such that antibiotic use is standardized and evidence based.42 
Interventions used in ASPs include avoidance of use of broad-spectrum antimicrobials, optimization 
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of dose and route of administration per patient, and customization of duration of therapy such that 
antibiotic use is curative, rather than palliative, in nature.42 In high-income settings, ASPs have been 
shown to reduce the emergence of AMR, but evidence for their effectiveness in LMICs is 
limited.24,43 Three studies included in this review suggest implementation of ASPs as control 
strategies for AMR in LMICs.  
Bhalla et al. 2016 assessed the effectiveness of an ASP implemented in the MSF 
Reconstructive Surgery Project in Amman, Jordan.24 The Reconstructive Surgery Project treats about 
50 patients per month, predominantly from Iraq, Syria, and Yemen.24 At this center, patients with 
suspected osteomyelitis (a type of bone infection) undergo exploratory surgery, during which tissue 
samples are collected and tested for resistance.24 The authors found that of those carrying resistant 
pathogens, the most common were cephalosporin-resistant Enterobacteriaceae or methicillin-resistant 
Staphylococcus aureus.24 To help control spread of these resistant pathogens, an ASP team was 
assembled in October, 2013 and composed of a physician and a pharmacist.24 They were tasked with 
using patient-level microbiology results to inform decisions of antibiotic selection, dose of 
medication, duration of treatment, and route of administration.24 Within the first year of the 
program, the ASP team recommended a change in the antibiotic regimen of 45% of patients (106 of 
233 patients); the rate of acceptance of these recommendations by the medical team was 88% (94 of 
106 patients).24 The authors found that though patient load at this MSF center remained relativity 
the same, the ASP reduced antibiotic costs from $252,077 to <$159,948 in just one year.24 They 
credit the reduction in improper use of imipenem, shifts in prescribing practices (e.g., waiting to 
initiate treatment until after culture reporting), and increased responsibility for antibiotic 
management by surgeons as program changes that helped to reduce costs.24  
Fily et al. 2019 retrospectively analyzed laboratory data from the same MSF Reconstructive 
Surgery Project assessed by Bhalla et al. They analyzed 727 bone samples collected between October 
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2006 and December 2016 from war-wounded Iraqi, Yemeni, and Syrian patients.12 Their objective 
was to describe first-line antibiotic resistance (FLAR) among civilians at risk for post-traumatic 
osteomyelitis (PTO) and to identify patient risk factors for PTO.12 Commensal pathogens, 
environmental contamination, and nosocomial spread of MDR pathogens are all causes of PTO in 
LMICs and particularly in conflicted-afflicted LMICs.12 PTO treatment includes prolonged antibiotic 
use, aggressive debridement and, in some cases, reconstructive surgery may be required. 12 Thus, the 
emergence or transmission of MDR pathogens poses significant threat to effective PTO treatment 
and may impact patient outcomes. The authors found that of the 727 patient isolates analyzed, 
roughly 50% were FLAR; of those resistant pathogen strains identified, 60.5% were S. aures.12 These 
pathogens were found to be resistant to fluroquinolones, rifampin, and oxacillan.12 A multivariable 
analysis conducted by the authors revealed that FLAR infections were associated with lower 
extremity infection, time since injury <12 months (compared with >30 months), and with >3 
previous surgeries.12 Based on their findings, Fily et al. suggest the implementation of a strong ASP 
and use of second-line antibiotics when treating PTO in war-wounded patients.12 However, the 
authors make no references to the ASP implemented at this study site in 2016, as described by 
Bhalla et al., which is a limitation of their discussion.  
Alga and Wong et al. 2016 conducted an open cohort study with longitudinal data collected 
from war-wounded Syrian civilians seeking care at an MSF-supported hospital in Jordan between 
2014 and 2016.26 They collected data on 457 patients (86% male, mean age 27).26 The authors used 
logistic regression models to understand differences in outcome and resource use based on infection 
status.26 Infection status was determined by culture results and clinical presentation of the wound.26  
Eleven percent of their cohort had an infected war wound and of these, 73% of the infections were 
MDR.26 They identified Klebsiella pneumoniae, Enterobacteria, and Escherichia coli as the pathogen strains 
resistant to the most antimicrobials.26 According to their statistical analysis, those with infected war 
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wounds required an average of 12 surgeries when compared to non-infected patients, who required 
an average of five surgeries (p<0.00001).26 Further, infected patients were hospitalized for about 77 
days, as compared to 35 days for non-infected patients (p=0.000001).26 Patients with infected 
injuries were also subject to a higher number of amputations.26 The authors conclude that war-
wound infections are associated with high resource consumption, worsened clinical outcomes for 
patients, and a higher occurrence of MDR pathogens.26 Based on these findings, they call for the 
development of “antibiotic protocols and adaptations of surgical management” to better the quality 
of care received by patients suffering from war-related injuries.26  
Diagnostics and Surveillance (DS) 
The capacity for microbiological surveillance of disease emergence and spread is oftentimes limited 
in LMICs due to resource constraints. Challenges include financial barriers, absence of culture 
samples, and infrastructural constraints (e.g., water supply, electricity supply, waste management, 
etc.).43 Given these challenges, resistance is only sporadically tested for in many low-resource health 
clinics and hospitals.13 In extremely resource-limited regions, such as Gaza, AMR is only reported 
anecdotally with no capacity to gather data to support the extent of its prevalence.44 In order for 
ASPs to be effective, prescribers require specific and accurate information on the type of resistant 
pathogens that a patient carries in order to inform clinical decisions.43 Furthermore, ineffective or 
insufficient disease surveillance programs may be detrimental to infectious disease prevention and 
control efforts. One example is the spread of TB in LMICs. In 2016, nearly 40% of individuals 
worldwide – that is, nearly 4.1 million individuals – either failed to be diagnosed with TB or failed to 
have their disease status reported to a national TB surveillance program.45,46 Such gaps in surveillance 
efforts are significant given that TB ranked as the ninth leading cause of deaths globally that year 
and also that TB-causing pathogens rapidly acquire resistance to treatment.45,46 Specific and sensitive 
diagnostics and robust surveillance systems are therefore necessary for the control of infectious 
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diseases. By extension, these measures may also be necessary for adequate AMR control. Seven 
studies included in this review, a number of which focused on TB, discuss the importance of 
diagnostic tools and surveillance in AMR management.  
In Lebanon, Hamze et al. 2015 evaluated the efficacy of pyrosequencing technology to 
detect mycobacterium tuberculous resistant to rifampicin (RIF) and isoniazid (INH) in isolates 
collected from Syrian refugees and Lebanese patients.33 RIF and INH were of interest to the 
researchers as MDR-TB is defined by a resistance to both these antibiotics.33,34 Before the Syrian 
civil war started, Lebanon had seen a decrease in incident TB cases.33 However, as of 2014, nearly 
14% of  all TB cases in Lebanon were among Syrian nationals, with some number of these cases 
being MDR-TB.33 Traditional culture-based tests for resistant TB may take up to 4 weeks to yield 
results; the researchers wanted to test pyrosequencing assays as an alternative diagnostic tool.33 They 
found that pyrosequencing, which sequences short DNA segments, applied to 66 clinical isolates 
was able to detect INH-resistant strains with 72.6% sensitivity.33 Thus, the authors recommend the 
use of pyrosequencing as a rapid and sensitive diagnostic tool that should be used to inform clinical 
decisions regarding TB treatment.33  
Araj et al. 2016 conducted a retrospective study to generate data on TB and MDR-TB in 
Lebanon, given the lack of robust surveillance programs in the country.34 Their data sources 
included the National Tuberculosis Program (NTP) and the Clinical Microbiology Lab (CML) at the 
American University of Beirut.34 The goal of this study was to assess trends in TB incidence and 
prevalence in Lebanon from 1999 to 2013.34 The researchers found that in 2001, the incidence of TB 
was 13/100,000 population; by 2006, the incidence had dropped to 9/100,000 population.34 
However, by 2013 – two years after the onset of the civil war in Syria – the incidence of TB reached 
20/100,000.34 They conclude that this rise in TB incidence is attributable to TB cases in non-
Lebanese nationals and Syrian refugees.34 Among the identified MDR-TB cases, resistance was 
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highest to INH followed by resistance to RIF.34 The author’s cite limitations of their study as being 
incomplete and non-comprehensive data due to restricted reporting to TB surveillance programs.34 
They conclude that “rapid and reliable” diagnostics are necessary such that TB may be diagnosed 
early and treated.34 In their own labs at the American University of Beirut Medical Center, the 
authors employ automated instruments and the TB Gene Xpert (Cephid) as diagnostic tools.34 
In another study based in Lebanon, El Achkar et al. 2019 tested 720 samples collected by the 
Lebanese National TB program from patients suspected of having TB between June 1, 2016 
through May 31, 2017.35 Samples were collected from individuals from Syria, Lebanon, Ethiopia, 
Palestine, Bangladesh, and elsewhere.35 Two-hundred eighty four cases of TB were confirmed based 
on culture results and Xpert MTB/RIF (Cepheid) molecular testing.35 Xpert testing was also used to 
determine resistance. The authors found that of a subset of 250 patients, 2.8% were resistant to 
RIF.35 The authors used multivariable regression to test if prior TB infection was associated with 
RIF resistance and found that resistance was 22.8% among patients previously treated with the 
drug.35 They conclude that while resistance to RIF in their study population was fairly low, the three 
MDR-TB and three XDR-TB strains discovered in their study had “strong epidemic potential and 
complex resistance patterns.”35 The authors thus recommend that TB-positive patients in Lebanon 
be tested for drug resistance in order to better inform treatment decisions and to ensure that 
appropriate antibiotics are used.35 
In Pakistan, Ghafoor et al. 2012 conducted a cross-sectional study on TB management 
involving 139 patients (51% male, mean age 31) who resided in the Khyber Pakhtunkhwa (KP) 
Province.30 The KP Province was selected for this study in part due to the large population of 
Afghan refugees who live there, and also because conflict and displacement in the KP Province have 
disrupted past TB control efforts.30 The goal of this study was to describe the prevalence of MDR-
TB in this region by recruiting patients and sorting them into two groups: residents with TB who 
 20 
never received treatment (CAT I) and residents with TB who received treatment but failed to 
respond or relapsed (CAT II).30 The authors found that nearly 58% of patients in their study had 
MDR-TB: of those individuals, MDR-TB was more prevalent in the CAT II patients who failed 
treatment (76% prevalence) than in CAT I patients (62% prevalence).30 The authors conclude that 
patients with a history of TB treatment failure are uniquely at risk for MDR-TB.30 They further state 
that improved disease and resistance surveillance are important aspects of TB management in this 
region.30  
In Turkey, Dogru et al. 2017 conducted a retrospective comparative analysis of incident TB 
cases and treatment success between Turkish and Syrian patients registered at the TB Outpatient 
Clinic in the Hatay Province between 2010 and 2013.38 This province was selected for the study as it 
is home to a high number of displaced Syrian refugees.38 The goal of the study was to record 
incident TB cases and compare treatment success between Turkish and Syrian patient populations.38 
The authors enrolled 178 Turkish patients (67% male, mean age 45) and 33 Syrian patients (61% 
male, mean age 32) to the study (n=211).38 It was found that treatment success rates amongst Syrian 
patients were lower than Turkish patients (64% vs. 89%, p<0.001) and that Syrian patients failed to 
complete treatment at a higher rate than Turkish patients (30% vs. 4%, p<0.001).38 Resistant TB was 
documented in 3 Turkish patients and 1 Syrian patient in this study population.38 To account for the 
lower treatment success rate in Syrian refugee patients, the authors recommend the implementation 
of a national TB control program that emphasizes the surveillance and treatment of refugees with 
TB.38  
The authors of two studies discussed improved diagnostics and surveillance for diseases 
other than TB. The first study was by Salloum et al. 2018. As a part of their case report, these 
researchers conducted a comparative genome analysis of a MDR Streptococcus pneumoniae responsible 
for the death of a 10-month old Syrian infant in Lebanon.36 They compared this isolate with 24 
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other S. pneumoniae genome sequences which they obtained from a publicly available database.36 The 
researchers investigated virulence factors, resistance mechanisms, and other characteristics of the 
strains in their comparison.36 They found that the isolate from the Syrian infant exhibited resistance 
to a number of drugs and also that regions of the genome were highly diverse, which the authors 
state “could account for the pronounced invasiveness of this isolate.”36 Given the isolates potential 
for rapid spread, the authors suggest the implementation of surveillance for S. pneumoniae in 
Lebanon, and recommend the use of whole genome sequencing to support these efforts.36   
The second study was by Fily et al. 2019, who analyzed bone biopsy samples collected from 
Iraqi, Syrian, and Yemeni patients with infected war wounds presenting for care at an MSF-
supported program in Jordan (full study described under ASP). These authors cite missing data 
(particularly on Iraqi patients), sample contamination, and the “laboratory origin of their database” 
as limitations of their analyses.12 To circumvent sample contamination concerns, the authors only 
tested bone biopsy cultures for antibiotic susceptibility, as tests using deep tissue samples lack 
sensitivity and specificity.12 Based on their experiences, the authors state that improved laboratory 
conditions and enhanced data collection and management are necessary to appropriately manage S. 
aureus and Enterobacteriaceae resistance in patients with PTO.12   
Education (E) 
The use of any antimicrobial applies selective pressure on pathogenic organisms, facilitating the 
emergence of drug-resistant pathogen strains.47 The overuse and misuse of antibiotics exacerbates 
this process. For example, despite antibiotics being ineffective for the treatment of viral infections, 
they are oftentimes prescribed in high-income settings to treat coughs, colds, and viral sore throats.47 
In countries such as Syria and Lebanon, antibiotics are readily available for purchase over the 
counter and without a prescription, which make the problem of overuse particularly challenging to 
address.48 Therefore, increased education on appropriate antibiotic usage on the population and 
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clinical level is often cited as necessary steps towards controlling these key drivers of AMR. Two 
studies included in this review address education as an AMR control strategy.  
In Jordan, Al Baz et al. 2017 used a cross-sectional, interviewer administered survey to study 
the knowledge, attitudes, and behaviors of Palestinian refugees (18% male, median age 32) regarding 
their antibiotic use.27 The 250 refugees who participated in this study were recruited at one of four 
United Nations Relief and Works Agency (UNRWA) health centers.27 Antibiotic use amongst this 
population was high, with 47% reporting one or more uses of antibiotics in the three months prior 
to survey administration.27 Self-medication – defined by study authors as “using leftover antibiotics, 
sharing antibiotics at home and purchasing antibiotics over the counter without prescription” – was 
also high.27 Of the respondents, 63% reported that they shared their antibiotics with others, 38% 
had used leftover antibiotics, and 60% purchased their drugs over the counter.27 The authors used 
logistic regression to model inappropriate antibiotic use. After adjusting for potential confounders, 
they found that patients who perceived there to be long wait times at health clinic had two times the 
risk of self-medication compared to those who perceived short wait times.27 These individual also 
had 1.7 times the odds of purchasing drugs over the counter.27 Income, age, employment, and 
education level were not found to significantly affect self-medication in this study population.27 
Given these findings, the authors recommend that interventions work on the community-level to 
promote education on appropriate antibiotic use.27 Also, given that 90% of respondents indicated 
that they trust their healthcare providers, the authors encourage increased counseling from the 
medical staff on appropriate antibiotic use.27  
Another study based in Jordan was by Alga and Herzog et al. 2018a, who conducted a 
qualitative study on physicians employed in an MSF-supported hospital to capture their perspective 
on AMR and hospital-based infections (full study described under IPC). Physicians in this study 
regarded patient behavior as a contributing factor to AMR: notably, they cited concerns over 
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patients’ ability to purchase drugs over the counter, as well as premature discontinuation of 
antibiotic use by patients.25 No physician in this study identified a direct link between the emergence 
of a HAI and the spread of AMR, despite these two factors being interrelated.25 Further, physicians 
had variable opinions on behaviors that may result in HAIs – e.g., hand hygiene was mentioned by 
some physicians as a behavioral factor that does contribute to the emergence of HAIs, while it was 
mentioned by others as a factor that does not contribute to HAIs.25 Based on these findings, the 
authors recommend increased training of healthcare professionals on the importance of hand 
hygiene compliance.25 They also recommend increased resource allocation as an intervention to 
improve adherence to hygiene protocols.25    
Other (O) 
Combination antibiotic therapies are believed to be an effective treatment approach for patients 
carrying resistant pathogens.49 Many infectious agents mutate and acquire resistance faster than new 
medications can be developed to treat patients; careful combination of existing therapies is a means 
of killing these resistant agents and allows for increased therapy options in lieu of novel scientific 
advances.49 Combination therapies are currently in use to treat resistant TB, human 
immunodeficiency virus (HIV), and malaria.29,49 One study included in this review considered 
combination therapy use as an intervention on AMR. 
In Pakistan, Kolaczinski et al. 2012 recruited 308 Afghan refugees (58% male) with 
falciparum malaria from five villages near the Peshawar Provence for a randomized control trial.29 
They randomized participants to one of six treatment arms in order to determine which treatment 
arm was most effective against malaria.29 The treatment arms were as follows: (1) chloroquine (CQ); 
(2) CQ + single dose of gametocytocidal primaquine (PQ); (3) CQ + three doses of artesunate (AS); 
(4) sulfadoxine-pyrimethamine (SP); (5) SP + single dose PQ; (6) SP + three doses AS.29 At the time 
that the study was initiated, CQ was the first-line treatment used for malaria, despite widespread 
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resistance to the drug.29 In their study, the authors found that patients treated with CQ had a 
treatment failure rate of 81% at 28 days follow-up.29 However, patients treated with SP + AS had a 
failure rate of 2.4% at follow-up.29 Based on these findings, CQ treatment was replaced with SP + 
AS combination therapy in the World Health Organization Eastern Mediterranean Region.29 The 
authors caution, however, that mono-therapeutic use of SP, which is still common in the region, 
may lead to future resistance to SP.29  
Protocols and guidelines used to treat civilians with war injuries were first developed by the 
International Committee of the Red Cross (ICRC) as early as 1988.50 Today, MSF-supported 
hospitals continue to adhere to ICRC guidelines for the treatment of civilians harmed during 
conflict.28 As discussed in the IPC section of this paper, appropriate management of war wounds is 
necessary to circumvent infection and the subsequent emergence and spread of AMR pathogens. 
However, healthcare workers in resource-limited settings are not always able to fully comply.28 One 
study included in this review considered the development of new guidelines and protocols for 
conflict-afflicted settings as a way to improve adherence and compliance.   
Alga and Herzog et al. conducted two separate qualitative studies with physicians employed 
by an MSF-supported hospital in Jordan. The first study (Alga and Herzog 2018a) was described in 
the IPC and E sections of this review. Their second study (Alga and Herzog 2018b) sought to 
capture physician opinion regarding perceived challenges to war wound management in the hospital 
setting.28 In total, they conducted 10 semi-structured interviews with physicians (60% male, mean 
age 37), transcribed the interviews, and content analyzed them.28 They found that the largest barrier 
to appropriate wound management reported in this setting was poor protocol adherence.28 Some 
barriers to adherence identified by physicians included: “(i) lack of medication or equipment, (ii) lack 
of space, (iii) patient and caregiver behavior.”28 The authors point out that these barriers are not 
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insurmountable. To overcome them, they suggest that future studies be conducted in order to 
develop new guidelines and protocols for resource-constrained hospitals.28 
DISCUSSION 
Main Findings  
The interventions identified in this scoping review predominantly fall into five categories: infection 
prevention and control (discussed in four studies); antibiotic stewardship programs (discussed in 
three studies); diagnostics and surveillance (discussed in seven studies); education (discussed in two 
studies); and other (discussed in two studies).  
While an initial goal of this analysis was to identify “best” control strategies for AMR in 
conflict-afflicted LMICs, a majority of the articles deemed eligible for inclusion did not offer a 
discussion of the effectiveness of their proposed interventions. Further, the complexity of the issue 
at hand makes it apparent that no one intervention is likely to be sufficient in managing the 
emergence and spread of AMR. Only three studies included in this review assessed the effectiveness 
of their proposed interventions. Bhalla et al. 2016 assessed the implementation of an ASP in a health 
clinic in Jordan and found that it did reduce antibiotic costs and improved antibiotic utilization 
practices.24 Hamze et al. 2015 explored lab diagnostics and found that use of pyrosequencing 
technology improved sensitivity testing for MDR-TB in Jordan and also allowed for more rapid 
testing for resistance.33 Kolaczkinski et al. 2012 showed that individuals treated with SP + AS had 
lower clinical failure rates during malaria treatment than those treated with CQ, a drug which 
malarial pathogens are highly resistant to.29 These studies provide support for ASPs, DS, and 
combination therapy, respectively.  
Though based on primary research findings and the authors’ expertise, recommendations 
offered in the remaining papers were at best speculative given the limited research to support the 
effectiveness of the interventions in low-resource settings. Research on the feasibility and utility of 
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IPC, education, and implementation of new guidelines is especially needed given that no studies 
included in this review spoke to their effectiveness.   
To further contextualize the findings of this scoping review, semi-structured qualitative 
interviews were conducted with experts to gain their opinions on the identified intervention 
categories. Interlocutors included: a physician at the Syrian America Medical Society (SAMS) (P1); an 
academic with expertise on AMR in conflict-afflicted countries (P2); a doctor and clinical leader on 
AMR at MSF (P3); and a microbiologist at MSF (P4). Two main takeaways emerged from these 
interviews: (1) heavy metals and environmental contaminants due to warfare are key drivers of AMR 
and (2) interventions must be tailored to the resource availability of a given region.  
Role of Heavy Metals 
A. baumannii is regarded as one of the most burdensome pathogens to emerge and cause infection in 
times of conflict.iv This bacterial pathogen readily acquires multi-drug resistance and spreads quickly 
both nosocomially and within the community.51 A. baumannii has a number of resistance 
mechanisms, but a primary mechanism is biofilm formation, which protects the pathogen from 
drugs and host immune response.51 A. baumannii was documented as being the most prevalent 
infection-causing pathogen in war-wounded individuals during wars in Iraq, Lebanon, and 
Afghanistan.51–53 In fact, this pathogen became so well known for its role in causing wound 
infections in U.S. soldiers returning from Iraq that it was nicknamed “Iraqibacter.”53    
Heavy metals play a role in selecting for resistance amongst pathogen species and are 
increasingly being identified as key drivers of resistant A. baumannii infection in war-wounded 
individuals.53 Heavy metals, defined as a “group of non-biodegradable metals and semi-metals 
(Metalloids),” are readily available in the environment and are often used in the development of 
 
iv This pathogen is also described by Rafei and Dabbousi et al. 2013 and Rafei and Pailhories et al. 2015 in the IPC 
section of this paper. 
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antimicrobials and chemotherapies.53 Heavy metals are also used in weapon production, and are 
present in large quantities in missiles, bullets, military vehicles, and explosives.53 Specific resistance 
mechanisms related to heavy metals are beyond the scope of this paper and are described elsewhere 
by Bazzi et al. 2020.53 However, their main importance to this discussion is their role in applying a 
selective pressure that allows for the persistence of resistant pathogens.54  
Widescale weapon use contaminates the environment with abnormal levels of heavy metals 
and, therefore, warfare has direct ecological impacts that drive AMR.55 While supplementary factors 
such as inappropriate antibiotic use and inadequate antibiotic stewardship likely play a role in the 
emergence and spread of AMR in conflict-afflicted regions, it is critical that the issue of AMR at 
large not be reduced to a behavioral one. This point is best explained by P2, an academic with 
expertise in the political and environmental ramifications of warfare on AMR. When asked what he 
believed the role of antibiotic stewardship to be in the global response to AMR, he said the 
following:  
“Yes, I think that the risk of… of obscuring the conflict, in terms of what it’s 
doing and in terms of the environmental damage and the physical injuries and 
the destruction of these healthcare, you end up really reducing this problem to 
really, a behavioral problem. And you are expecting people in a war zone or in 
a conflict setting, that they will have to kind of abide by WHO guidelines while 
they are being bombed left and right by whoever… I mean, it feels like 
sometimes people are living in La La Land when they talk like that, you know? 
But all we need to improve stewardship and improve antibiotic prescription. I 
mean, but when you go to Idlib or Mosul and you see the situation… this is 
the last of your concerns. Having said that, that’s not necessarily a bad idea, to 
begin to raise awareness and explore these problems and the prevention. But 
again, the issue – the bigger issue – is the whole war and the war ecology…” 
 
This excerpt makes clear the additional considerations that must be kept in mind when an LMIC is 
confronted not only with a limitation of resources, but also active violent conflict. While there are 
behavioral components of AMR that health systems might address with interventions identified in 
this paper – notably, education and the implementation of ASPs – it is crucial to recognize that 
some barriers to effective AMR control are simply beyond the capacity of already struggling health 
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systems and people. In idealistic terms, the best control for AMR in conflict-afflicted LMICs would 
be an immediate ceasefire of all violent conflict, especially in the MENA region. In the absence of 
such ceasefire, however, the global health community must think more strategically about AMR 
interventions that are tailored to local capabilities and capacities. MSF has been a leader in such 
thinking, and has presented a structure for deciding on effective AMR interventions in conflicted-
afflicted LMICs. Their intervention recommendations are explored below.  
Tailoring Interventions  
In 2015, the WHO released a report titled the “Global Action Plan on Antimicrobial Resistance.” 
The five objectives identified in this plan include: (1) increased educational awareness of AMR and 
its drivers; (2) improved surveillance of and research on AMR; (3) infection prevention and control; 
(4) optimization of antibiotic use in humans and animals; and (5) sustained investment in the 
development of new drugs, therapies, and diagnostics.56 While this report acknowledges that AMR 
prevention and control necessarily looks different in LMICs, the guidance offered to these countries 
is minimal and ultimately lacks the specificity required for effective intervention. The authors of the 
report recognize this limitation and identify lack of research on treatment and IPC, as well as 
minimal data, as barriers to effective AMR control in LMICs.56   
In the same year, MSF released their “Roadmap on Antibacterial Resistance.” Given the 
presence of MSF predominately in LMICs, this document explicitly addresses control and its 
associated challenges in low-resource settings. Many of the objectives identified in the MSF plan are 
comparable to those in the WHO plan – e.g., stewardship, surveillance, improved lab diagnostics, 
infection prevention, etc.57 However, the plans differ in that MSF writes specifically on antibiotic 
resistance (ABR), rather than AMR more generally, and MSF also tailors their recommendations 
based on existent lab and diagnostic infrastructure in each of their operational sites.57 In a 
subsequent 2019-2020 strategic plan released by MSF, they propose two “packages” for ABR 
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control. The first package recommends that all MSF healthcare facilities – regardless of their 
capacity to conduct microbiology research – should, at the minimum, implement an ASP and an IPC 
plan.58 The second package, called a “full package,” recommends the implementation of an ASP, 
IPC, and “access to microbiology.”58 This access would ensure that appropriate diagnostic tools and 
lab infrastructure are in place such that identification of infection-causing agents, tailored antibiotic 
treatment with specificity to the infectious pathogen, and time-sensitive detection of resistance are 
possible.58 Given the importance of microbiology data in ABR control, MSF has helped to support 
microbiology labs at 14 of their project sites, including a lab in Jordan.59  
However, the establishment of a lab is not always feasible, and it is in the absence of 
microbiology that interventions must be creatively modified to fit local capacities and resources. 
According to an MSF researcher who works on ABR (P3), education- and behavior-based 
interventions become particularly important in regions that lack microbiology access. P3 identifies 
the following as supplemental actions that might be taken in regions where full-package ABR 
control is not possible: 
“The only thing that we do in places that is where there is no access to 
antibiotic… we try to improve the clinical scheme of the people doing external 
consultation, or we call it OPD, is outpatient departments. This person is key 
as well in the most of the places that we work because this person will decide 
if one patient will get some antibiotics or not or if the patient needs to be 
hospitalized or not. We developed… a tool that is called e-Care and the e-Care 
is kind of like an app based with the tablet and the ideas to help the clinician 
to take the right decision.” 
 
Here, P3 is describing an iteration of an ASP program which uses the outpatient setting as a 
backdrop for intervention. While an app-based system presumes access to technology and Internet 
service, this strategy provides an example of how interventions identified in this paper may be 
adapted to the context in which they are implemented. Investment in improved lab diagnostics is 
sorely needed in LMICs most affected by conflict; however, there are other opportunities to 
intervene in the absence of microbiology. When asked if they believed that improved lab diagnostics 
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was the predominant intervention needed to curb AMR, a microbiologist who has helped MSF to 
open a number of labs around the world (P4) disagreed and said the following: 
“No, I would say infection prevention and control as... as it is really like the, 
the, the main pillar. It’s like, without that, you can rationalize the use of all the 
antibiotics, you can put diagnostic tests everywhere. You are just going to 
diagnose what you are creating in your own hospital, which is going to be a 
loss of time, loss of money, and loss of life.” 
 
In other words, hospitals and healthcare facilities must take sufficient action to try and prevent the 
emergence of resistance-prone infections altogether. Otherwise, the implementation of ASPs and 
the use of lab diagnostics may just be reactionary measures that fail to adequately address the roots 
of the problem. However, P4 cautions that the implementation of IPC measures is no easy task. 
Challenges to IPC range from war-related factors (e.g., heavy metals in the environment) to resource 
constraints in the hospital setting. As thus, P4 believes that future research is needed in order to 
inform effective IPC program design and to improve adherence to IPC guidelines by medical staff.   
In the interim, actions taken by MSF and other organizations with expertise in conflict-
afflicted LMICs should be studied closely as examples of how interventions on AMR may be 
formulated and implemented. As P3 states in their interview, despite there being a number of 
different guidelines that have been proposed by public and global health bodies, the most successful 
control of AMR will only be possible if healthcare systems themselves are provided with the capacity 
to conduct research and understand the epidemiological spread of pathogens and resistance in their 
facilities. In the absence of such research and data, AMR interventions will continue to lack the 
epidemiologic grounding needed to be effective. Furthermore, as P2 and P4 discuss, interventions 
must equally target both the emergence and spread of AMR; while these phenomena are certainly 
related to one another, they are also distinct issues that require their own specific interventions.   
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LIMITATIONS  
There are a number of limitations to this scoping review. Foremost, all searchers were conducted in 
English and only papers published in English were eligible for inclusion, despite the focus of this 
review on regions where English is not the predominant language. Additionally, this review was 
limited to primary research on only four conflicted-afflicted LMICs in the MENA region. It is 
possible that other intervention strategies might have been identified if the search were expanded to 
include grey literature or other conflict-afflicted countries around the world. A limitation of the 
qualitative component of this paper was that only four interviews were able to be completed, despite 
the extension of more than ten interview requests. However, the completed interviews did provide 
key insights – a greater number and diversity of interviews in future research of this nature would 
allow for more rigorous and theory-based thematic analyses of expert opinion.   
CONCLUSION  
The challenges associated with containing the emergence and spread of AMR are exacerbated by 
violence, conflict, and displacement. Conflict-afflicted LMICs not only face resource limitations, but 
must also find ways to care for and treat injured individuals who carry increasingly-resistant 
pathogens. This scoping review identified five key intervention categories for AMR control in 
conflict-afflicted LMICs: (1) infection prevention and control; (2) antibiotic stewardship programs; 
(3) diagnostics and surveillance; (4) education; and (5) other. Based on what is currently known in 
the literature and expert opinions, a major takeaway from this review is that improved lab 
diagnostics, implementation of surveillance programs, and infection prevention and control should 
all be prioritized in efforts to control AMR in conflicted-afflicted LMICs. However, there is limited 
primary research on the effectiveness of all identified intervention strategies in such settings. In 
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particular, a major gap in the literature identified by this review was the absence of primary studies 
on the effectiveness of education-based interventions and IPC in conflict-afflicted countries.   
As violent conflict persists around the world, it is critical that the threat of antimicrobial 
resistance is responded to appropriately and immediately. In order to respond, however, increased 
data and primary research on AMR in conflict-afflicted regions is sorely needed. To be effective, 
interventions must be uniquely tailored to the political, social, and ecological realities of the 
countries that they are implemented in. Furthermore, the problems and challenges identified 
throughout this paper go far beyond countries actively experiencing violence or warfare: resistant 
pathogens oftentimes become unwanted cargo, carried unknowingly by those fleeing humanitarian 
disaster. The global health community should leverage this fact to increase research funding and 
attention to the unique dangers of AMR in conflict-afflicted regions – e.g., its exacerbated potential 
for spread in these settings. In engaging in such research, however, it is critically important that 
displaced individuals and refugees themselves are not pathologized and solely blamed for AMR. As 
P2 explained in his interview, the entire war system – including the targeted breakdown of 
healthcare infrastructure, sanctions that render it impossible to import needed medications and 
medical supplies, impact of weaponry on the environment and water sources, and so on – must all 
be considered as drivers of AMR. Ultimately, the struggle to provide care to those most in need will 
only increase as antibiotics continue to fail to cure illness and infection. Prompt action by the global 
health community is necessary; the findings of this analysis provide preliminary guidance on where 
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Conflict  (1)  conflict*[tw] OR warfare[tw] OR 
war[tw] OR displace*[tw] OR refugee*[tw] 
OR violence[mesh] OR violen*[tw] OR 
war-related injuries[mesh] OR warfare and 
armed conflicts[mesh] OR refugees[mesh] 
OR wound infection[mesh] OR "asylum 
seeker"[tw] OR "war wound*"[tw] 
(1) (((violen* OR armed conflict OR war-
related injuries OR refugee* or displac* 
OR wound infection OR asylum seeker 




(1)  TITLE-ABS-KEY (conflict* OR war* 
OR displac* OR refugee* OR "armed 
conflict*" OR “war-related injuries” OR 





(2)  Anti-Bacterial Agents / therapeutic 
use[mesh] OR Drug Utilization / 
standards[mesh] OR antibacterial 
agents/therapeutic use[mesh] OR drug 
resistance, bacterial[mesh] OR resistan*[tw] 
OR AMR[tw] OR ABR[tw] OR Bacterial 
Infections/microbiology[mesh] OR 
MDR[tw] 
(2) ((drug resistance/ OR drug resistance, 
microbial/ OR drug resistance, bacterial/ 
OR drug resistance, multiple, bacterial/ 
OR drug resistance, viral/ OR drug 
resistance, multiple, viral/ or drug 
resistance, multiple/) OR (AMR OR MDR 
OR ABR OR resistan*).mp.) 
(2)  TITLE-ABS-KEY ("drug resistan*" 
OR "AMR" OR "MDR" OR "multidrug 
resistan*" OR "acquired resistance" OR 
“ABR” OR "bacterial resistance”)   
 
Region  (3)  Turkey[tw] OR Turkish[tw] OR 
Jordan[tw] OR Jordanian*[tw] OR 
Lebanon[tw] OR Lebanese[tw] OR 
Pakistan*[tw] OR middle east*[tw] OR 
Middle East[mh:noexp] OR Turkey[mh] 
OR Jordan[mh] OR Pakistan[mh] OR 
Lebanon[mh] 
(3) ((Middle East/) OR (Jordan OR 
Jordanian OR Lebanon OR Lebanese OR 
Turkey OR Turkish OR Pakistan OR 
Pakistani OR Middle East).mp.) 
 
(3) TITLE-ABS-KEY (Turkey OR Turkish 
OR Jordan OR Jordanian OR Lebanon 
OR Lebanese OR Pakistan OR Pakistani 
OR “Middle East”) 
Full Search  1 AND 2 AND 3 1 AND 2 AND 3  1 AND 2 AND 3 
 ii 
Table 2. Description of Final Study Set  
 




Bhalla et al., 
2016 Jordan 
Iraqi, Syrian, and Yemini 
patients with chronic 
multidrug-resistant 
infections 
Patients treated at the MSF Reconstructive Surgery Project in Amman; ASP 
implemented by MSF at this site; program reduced antibiotic cost by ~$92,129 
over one-year period 
- 
Al Baz et al., 
2017 Jordan 
Palestinian refugees (18% 
male, median age 32) 
Patients treated at one of four UNRWA health centers; interviewed regarding 
knowledge and use of antibiotics; 63% shared antibiotics, 38% used leftover 
antibiotics, 60% purchased drugs over-the-counter 
250 
Alga & Herzog 
et al., 2018a Jordan 
Physicians (55% male, mean 
age 37) 
Physicians employed by an MSF-supported hospital; interviewed regarding 
views and attitudes on AMR and HAIs; most providers did not acknowledge a 
link between AMR and HAIs 
10 
Alga & Herzog 
et al., 2018b Jordan 
Physicians (60% male, mean 
age 37) 
Physicians employed by an MSF-supported hospital; interviewed regarding 
perceived challenges to war wound management; identified lack of resources as 
barrier to protocol adherence 
10 
Alga & Wong 
et al., 2018 Jordan 
Syrian civilians (86% male, 
mean age 27) 
Patients received surgical treatment for conflict-related injuries at an MSF-
supported hospital; open cohort study with longitudinal data collection was 
conducted; 73% of patients had MDR infections; length of stay for patients with 
MDR infection was about 42 days longer than patients without infection 
457 
Fily et al., 2019 Jordan 
Iraqi, Syrian, and Yemeni 
civilians with war-related 
injuries 
Patients admitted to an MSF-supported program in Jordan for treatment; lab 
data from the MSF database was retrospectively analyzed; 77% of patients had 
> 1 sample positive for FLAR; FLAR was associated with lower limb injury, 
>12 months since injury, and more than 3 previous surgeries 
727 
Pakistan 
Ghafoor et al., 
2012 Pakistan 
Residents of Khyber 
Pakhtunkhwa province (51% 
male, mean age 31) 
Cross-sectional study to determine prevalence of MDR-TB in this region was 
conducted; recruited patients who never received treatment for TB (CAT I) and 
patients who received treatment and failed or relapsed (CAT II); MDR-TB 
found to be more prevalent in CAT II patients who previously failed treatment 
than CAT I patients 
139 
Kolaczinski et 
al., 2012 Pakistan 
Afghan refugees (58% male) 
with falciparum malaria 
Refugees recruited from five different villages near the Peshawar Provence; 
randomized to one of six treatment arms; chloroquine was deemed 
inappropriate for malaria treatment; sulfadoxine-pyrimethamine (SP) + 







Lebanon Syrian refugees with war-related wounds 
Patients treated at the Tripoli Government Hospital; patient isolates were 
collected and tested for carbapenem-resistant A. baumannii; four isolates 






Syrian refugees and 
Lebanese patients (78% 
male, mean age 40) 
Patients treated at different hospitals in Tripoli, Lebanon; isolates were collected 
and tested for resistance to antibiotics; 60% of isolates exhibited carbapenem 
resistance 
116 
Hamze et al., 
2015 Lebanon Syrian and Lebanese patient 
Patient isolates collected by the National Commission for Biotechnology in 
Syria and the Azm Center for Research in Biotechnology in Beirut; utility of 
pyrosequencing technology for the detection of MDR-TB was evaluated; 
technology was found to be 72.6% sensitive to INH resistance 
66 
Araj et al., 
2016 Lebanon 
Individuals residing in 
Lebanon 
Data collected by the National Tuberculosis Program (NTP) or the Clinical 
Microbiology Laboratory (CML) at the American University of Beirut Medical 
Center; data was retrospectively analyzed; >7500 cases of TB reported since 
2011; increase in TB cases likely attributable to influx of Syrian refugees 
- 
Salloum et al., 
2018 Lebanon Syrian infant 
Case report on S. pneumoniae responsible for the death of 10-month old Syrian 
infant; comparative genome analysis of S. pneumonia from infant and 24 other S. 
pneumoniae genomes from publicly available dataset was conducted; isolate 
collected from infant exhibited potential for “pronounced invasiveness” and 
resistance 
25 
El Achkar et 
al., 2019 Lebanon 
Individuals with suspected 
cases of TB (51% male, 
mean age 34)  
Data reported to a national TB program in Lebanon; data was retrospectively 
analyzed; 250 confirmed cases of TB; 3% of cases found to be resistant to RIF 720 
Turkey 
Yuce et al., 
2017 Turkey 
Syrian patients (58% male, 
mean age 27) 
Patients treated for burns at the Dr. Lutfi Kirdar Kartal Educating and Training 
Hospital Burn Centre of Istanbul; patient data retrospectively analyzed; high 
prevalence of infection with resistant pathogens observed in patients with 
conflict-related burns 
43 
Dogru et al., 
2017 Turkey 
Syrian patients (61% male, 
mean age 32) and Turkish 
patients (67% male, mean 
age 45) 
Patients registered to the Hatay TB Outpatient Clinic; retrospective comparative 
analysis of incident TB cases and treatment success between Turkish and Syrian 
patients was conducted; treatment success rate amongst Syrian patients found to 








Table 3. Recommended AMR Control Strategies  
 




Intervention Outcomes and Details 
Strategy Recommended and Evidence for Effectiveness Provided in Article 
Bhalla et al., 
2016 ASP 
Implementation of antibiotic 
stewardship program that adhere to 
guidelines set by the Centers for Disease 
Control (CDC) 
2013-2014 
When compared to the previous year, 
antibiotic costs following ASP 
implementation dropped from ~$252,077 to 
~$159,948 
Hamze et al., 
2015 DS 
Use of pyrosequencing for rapid and 
highly-sensitive detection of MDR-TB 
resistant to RIF and INH 
- 
Culture-based screening for MDR-TB can 
take up to 4-weeks; pyrosequencing 
technology more rapidly detects resistance to 
INH with 72.6% sensitivity 
Kolaczinski et 
al., 2012 O 
Change in first-line malaria treatment 
from chloroquine to combination 
therapy (SP + AS) 
2000-2003 
Patients treated with chloroquine had a 
clinical failure rate of 81% at 28 days follow-
up; patients treated with SP + AS had a 
treatment failure rate of 2.4% at follow-up 
Strategy Recommended but no Evidence for Effectiveness Provided in Article** 
Ghafoor et al., 
2012 DS 
Implementation of MDR-TB 
surveillance program; monitor patients 






Utilization of IPC measures to prevent 






IPC Utilization of IPC measures to prevent spread of resistant A. baumannii 2011-2013 - 
Araj et al., 
2016 DS 
Improved lab diagnostics for more rapid 
and accurate MDR-TB testing - - 
Al Baz et al., 
2017 E 
Increased education on proper antibiotic 
use amongst refugee groups - - 
Dogru et al., 
2017 DS 
Implementation of national TB 
surveillance program 2010-2013 - 
Salloum et al., 
2017 DS 
Use of whole genome sequencing for 
TB surveillance - - 
Yuce et al. 
2017 IPC 
Accelerated transfer of burn victims to 
treatment centers 2011-2015 - 
 v 
Alga & Herzog 
et al., 2018a E, IPC 
Increased physician education on 
antibiotics and HAIs; improved IPC - - 
Alga & Herzog 
et al., 2018b O 
Development of war wound 
management protocols/guidelines 
specific to conflict-afflicted settings 
2015 - 
Alga & Wong 
et al., 2018 ASP 
Implementation of more rigorous 
protocols for antibiotic use 2014-2016 - 
Fily et al., 2019 ASP, DS Implementation of high-skill laboratories; implementation of ASPs 2006-2016 - 
El Achkar et 
al., 2019 DS 
Increased testing of TB resistance prior 
to treatment decisions; improved lab 
diagnostics 
2016-2017 - 
*  Abbreviations for control strategy categories: infection prevention and control (IPC); antibiotic stewardship program (ASP); diagnostics and surveillance (DS); 
education (E); other (O). 





























































599 records identified through 
database searching 
 
- PubMed: n=220 
- Embase: n=158 
- Scopus: n= 221 
 
447 records identified for title and 
abstract screening 
 399 records excluded  
 
- Published before Jan. 2010: n=156 
- Not topically relevant: n=237 
- Full-text not in English: n=6 
 
 48 records identified for full-text 
screening 
 32 records excluded  
 
- Not primary research: n=23 
- No discussion of control: n=9 
 16 studies included in review  
 
152 duplicate records removed  
